Please login to the form below

Not currently logged in

Pemphis vulgaris

This page shows the latest Pemphis vulgaris news and features for those working in and with pharma, biotech and healthcare.

GSK unit takes new ofatumumab formulation into phase III

GSK unit takes new ofatumumab formulation into phase III

The trial in patients with pemphigus vulgaris, a serious condition in which patients develop painful blisters in the mouth and on the skin that can become infected. ... At the moment the standard treatment for pemphigus vulgaris - which affects around

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...